The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
eMonarcHER: A phase 3 study of abemaciclib plus standard adjuvant endocrine therapy in patients with HR+, HER2+, node-positive, high-risk early breast cancer.
 
Sara M. Tolaney
Consulting or Advisory Role - Abbvie; AstraZeneca; Athenex; Bristol-Myers Squibb; Celldex; Certara Inc; CytomX Therapeutics; Daiichi Sankyo; Eisai; G1 Therapeutics; Genentech; Immunomedics/Gilead; Kyowa Hakko Kirin; Lilly; Merck; Mersana; NanoString Technologies; Nektar; Novartis; Odonate Therapeutics; OncoPep; Paxman; Pfizer; Puma Biotechnology; Samsung Bioepis; Sanofi; Seagen; Silverback Therapeutics
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cyclacel (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Lilly (Inst); Merck (Inst); NanoString Technologies (Inst); Nektar (Inst); Novartis (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Sanofi (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Celldex; Eisai; Genentech/Roche; Immunomedics; Lilly; Merck; NanoString Technologies; Nektar; Novartis; Pfizer; Puma Biotechnology
 
Lesley Fallowfield
Honoraria - Abbvie; Clovis Oncology; Genomic Health; MSD; NanoString Technologies; Novartis; Novartis; Pfizer; Voluntis
Consulting or Advisory Role - AstraZeneca; Genomic Health/Exact Sciences; Lilly; Puma Biotechnology; Roche; Seagen; Takeda; Voluntis
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst); Novartis
Travel, Accommodations, Expenses - Genomic Health
 
Peter A. Kaufman
Stock and Other Ownership Interests - Amgen
Honoraria - Lilly
Consulting or Advisory Role - AstraZeneca; Eisai; Lilly; Macrogenics; Merck; Pfizer; Polyphor; Roche/Genentech
Speakers' Bureau - Lilly
Research Funding - Eisai (Inst); Lilly (Inst); Macrogenics (Inst); Novartis (Inst); Pfizer (Inst); Polyphor (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Lilly; Macrogenics; Polyphor
 
Eva M. Ciruelos
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Pfizer; Roche
Speakers' Bureau - Lilly; Pfizer; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
Mary Corona Gainford
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Yi Lu
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Research Funding - Lilly
Travel, Accommodations, Expenses - Lilly
 
Karla Hurt
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Heather Ann Wasserstrom
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Yanyun Chen
No Relationships to Disclose
 
Shom Goel
Consulting or Advisory Role - Lilly; Pfizer
Speakers' Bureau - Novartis
Research Funding - G1 Therapeutics; Lilly
Travel, Accommodations, Expenses - Novartis